Clinical Trials Browser

Phase 2 × Squamous Cell Non-small Cell Lung Cancer × Nivolumab × Clear all

NCT01721759 2022-06-28

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Phase 2 Completed

117 enrolled 17 charts

Squamous Cell Non-small Cell Lung Cancer